Abstract
Developmental immunotoxicity (DIT) occurs when early-life events reshape immune development to the point of altering immune system responses, often with negative consequences for an organism. Within the vein of toxicology, such events include exposure to exogenous risk factors, including chemical, biological, or physical agents that change the course of immune system development. Early-life exposure to such events may result in suppression, hyperactivation , and/or misregulation of a host of immune responses to result in inflammatory diseases, allergy and asthma, autoimmune diseases, and/or decreased resistance to infectious agents. This chapter will review current issues associated with DIT, including an overview of current guidelines for assessing DIT in experimental animal models, lifetime health risks thought to be associated with DIT, the need for DIT testing in safety assessments of chemical substances, and the impacts of “twenty-first century toxicology” on DIT approaches and methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AW, Vahter M (2012) In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci 129:305–314
Arbibe L, Sansonetti PJ (2007) Epigenetic regulation of host response to LPS: causing tolerance while avoiding toll errancy. Cell Host Microbe 1:244–246
Arita A, Costa M (2009) Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 1:222–228
Barker D (1997) The fetal origins of coronary heart disease. Acta Paediatr 422:78–82
Barker DJ (2001) A new model for the origins of chronic disease. Med Health Care Philos 4:31–35
Bateson P, Barker D, Clutton-Brock T, Deb D, D’Udine B, Foley RA et al (2004) Developmental plasticity and human health. Nature 430:419–421
Ben-Shlomo Y (2007) Rising to the challenges and opportunities of life course epidemiology. Int J Epidemiol 36:481–483
Brown RC, Barone S Jr, Kimmel CA (2008) Children’s health risk assessment: incorporating a lifestage approach into the risk assessment process. Birth Defects Res B Dev Reprod Toxicol 83:511–521
Bunn TL, Parsons PJ, Kao E, Dietert RR (2001) Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol Sci 64:57–66
Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP (2008) What’s so special about the developing immune system? Int J Toxicol 27:223–254
Collinge M, Burns-Naas LA, Chellman GJ, Kawabata TT, Komocsar WJ, Piccotti JR, Shenton J, Wierda D (2012) Developmental immunotoxicity (DIT) testing of pharmacueticals: current practices, state of the science, knowledge gaps, and recommendations. J Immunotoxicol 9:210–230
Collins FA, Gray GM, Bucher JR (2008) Toxicology. Transforming environmental health protection. Science 319:906–907
Daston G, Faustman E, Ginsberg G, Fenner-Crisp P, Olin S, Sonawane B, McLaughlin TJ (2004) A framework for assessing risks to children from exposure to environmental agents. Environ Health Perspect 112:238–256
DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR (2012a) Current status of developmental immunotoxicity early-life patterns and testing. Toxicol Pathol 40:230–236
DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR (2012b) Developmental immunotoxicity (DIT): assays for evaluating effects of exogenous agents on development of the immune system. Curr Protoc Toxicol chapter 18:unit18.15
Dietert R (2009) Developmental immunotoxicology: focus on health risks. Chem Res Toxicol 22:17–23
Dietert RR (2011a) Fractal immunology and immune patterning: potential tools for immune protection and optimization. J Immunotoxicol 8:101–110
Dietert RR (2011b) Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod Toxicol 31:319–326
Dietert RR (2008) Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol 5:401–412
Dietert RR (2014) Developmental immunotoxicity, perinatal programming, and noncommunicable diseases: focus on human studies. Adv Med 2014:867805
Dietert RR, DeWitt J (2010) Developmental Immunotoxicity (DIT): the why, when, and how of DIT testing. In: Dietert RR (ed) Immunotoxicity testing methods and protocols. Humana Press, New York, pp. 17–25
Dietert RR, Etzel RA, Chen D, Halonen M, Holladay SD, Jarabek AM, Landreth K, Peden DB, Pinkerton K, Smialowicz RJ, Zoetis T (2000) Workshop to identify critical windows of exposure for children’s health: immune and respiratory systems work group summary. Environ Health Perspect 108(Suppl 3):483–490.
Dietert RR, DeWitt JC, Germolec DR, Zelikoff JT (2010) Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives. Eviron Health Perspect 118:1091–1099
Dietert RR, Holsapple MP (2007) Methodologies for developmental immunotoxicity (DIT) testing. Methods 41:123–131
Dietert RR, Lee JE, Hussain I, Piepenbrink M (2004) Developmental immunotoxicology of lead. Toxicol Appl Pharmacol 198:86–94
Dietert RR, Luebke RW (eds) (2012) Immunotoxicity, immune dysfunction, and chronic disease. Humana Press, New York
Dietert RR, Zelikoff JT (2010) Identifying patterns of immune-related disease: use in disease prevention and management. World J Pediatr 6:111–118
Dietert RR, Zelikoff JT (2009) Pediatric immune dysfunction and health risks following early-life immune insult. Curr Pediatr Rev 5:36–51
Dietert RR, Zelikoff JT (2008) Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res B Dev Reprod Toxicol 83:547–560
Fedeli D, Montani M, Carloni M, Nasuti C, Amici A, Gabbianelli R (2012) Leukocyte Nurr1 as peripheral biomarker of early-life environmental exposure to permethrin insecticide. Biomarkers 17:604–609
Filiberto A, Maccani M, Koestler D, Wilhelm-Benartzi C, Gagne L, Marsit C (2011) Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in the human placenta. Epigenetics 6:566–572
FRB (Federal Reserve Board) (2015) G.17—Industrial production and capacity utilization, industrial production for chemicals (NAICS=325). http://www.federalreserve.gov/. Accessed 3 Aug 2015
Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:391–397
Grandjean P, Poulsen LK, Heilmann C, Steuerwald U, Weihe P (2010) Allergy and sensitization during childhood associated with prenatal and lactational exposure to marine pollutants. Environ Health Perspect 118:1429–1433
Gundacker C, Hengstschläger M (2012) The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr 162:201
Halfon N, Hochstein M (2002) Life course health development: an integrated framework for developing health, policy, and research. Milbank Q 80:433–479
Hartung T, Corsini E (2013) Immunotoxicology: challenges in the 21st century and in vitro opportunities. ALTEX 30:4111–4426
Heilmann C, Budtz-Jørgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P (2010) Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect 118:1434–1438
Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jorgensen E (2006) Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med 3:e311
Hessel EV, Tonk EC, Bos PM, van Loveren H, Piersma AH (2015) Developmental immunotoxicity of chemicals in rodents and its possible regulatory impact. Crit Rev Toxicol 45:68–82
Holsapple MP, Paustenbach DJ, Charnley G, West LJ, Luster MI, Dietert RR, Burns-Naas LA (2004) Symposium summary: children’s health risk—what’s so special about the developing immune system? Toxicol Appl Pharmacol 199:61–70
Kang SH, Jung YH, Kim HY, Seo JH, Lee JY, Kwon JW, Hong SJ (2013) Effect of paracetamol use on the modification of the development of asthma by reactive oxygen species genes. Ann Allergy Asthma Immunol 110:364–369
Kanno Y, Vahedi G, Hirahara K, Singleton K, O’Shea JJ (2012) Transcriptional and epigenetic control of T helper cell specificiation: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30:707–731
Keil D, Dudley A, EuDaly J, Dempsey J, Butterworth L, Gilkeson G, Peden-Adams M (2004) Immunological and hematological effects observed in B6C3F1 mice exposed to JP-8 jet fuel for 14 days. J Toxicol Environ Health A 67:1109–1129
Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM (2009) N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol Sci 108:110–123
Krewski D, Andersen ME, Mantus E, Zeise L (2009) Toxicity in the 21st century: implications for human health risk assessment. Risk Anal 29:474–479
Landreth KS (2002) Critical windows in development of the rodent immune system. Hum Exp Toxicol 21:493–498
Lawn JE, Wilczynska-Ketende K, Cousens SN (2006) Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 35:706–718
Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, Black RE (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385:430–440
Louveau A, Smirnov I, Keyes TJ, Eccles JD, Fouhani SJ, Peske JD, Derecki NC, Castle D et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337–341
Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI (2006) The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B 9:1–26
Luster MI, Dean JH, Germolec DR (2003) Consensus workshop on methods to evaluate developmental immunotoxicity. Environ Health Perspect 111:579–583
Maccani JZ, Koestler DC, Houseman EA, Marsit CJ, Kelsey KT (2013) Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age. Epigenomics 5:619–630
MacGillivray DM, Kollmann TR (2014) The role of environmental factors in modulating immune responses in early life. Front Immunol 5:434
National Research Council (NRC) (2007). Toxicity testing in the 21st century: a vision and a strategy. Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council. http://www.nap.edu/catalog/11970.html
Ornoy A, Ergaz Z (2010) Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment. Int J Environ Res Public Health 7:364–379
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE (2008) Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104:144–154
Peden-Adams MM, Liu J, Knutson S, Dancik J, Bryant K, Bodine AB, Dickerson RL (2007) Alterations in immune function and CYP450 activity in adult male deer mice (Peromyscus maniculatus) following exposure to benzo[a]pyrene, pyrene, or chrysene. J Toxicol Environ Health A 70:1783–1791
Pennings JL, Jennen DG, Nygaard UC, Namork E, Haug LS, van Loveren H, Granum B (2015) Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol (Epub ahead of print) 13(2):173–180
Prescott S, Saffery R (2011) The role of epigenetic dysregulation in the epidemic of allergic disease. Clin Epigenetics 2:223–232
Renz H, Conrad M, Brand S, Teich R, Garn H, Pfefferle PI (2011) Allergic diseases, gene-environment interactions. Allergy 66:10–12
Robins JC, Marsit CJ, Padbury JF, Sharma SS (2011) Endocrine disruptors, environmental oxygen, epigenetics and pregnancy. Front Biosci 3:690–700
Rocha-Amador DO, Calderón J, Carrizales L, Costilla-Salazar R, Pérez-Maldonado IN (2011) Apoptosis of peripheral blood mononuclear cells in children exposed to arsenic and fluoride. Environ Toxicol Pharmacol 32:399–405
Sathyan P, Golden HB, Miranda RC (2007) Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 27:8546–8557
Schaible TD, Harris RA, Dowd SE, Smith CW, Kellermayer R (2011) Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 20:1687–1696
Selgrade MK (2007) Immunotoxicity: the risk is real. Toxicol Sci 100:328–332
Seiler A, Oelgeschläger M, Liebsch M, Pirow R, Riebeling C, Tralau T, Luch A (2011) Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays? Arch Toxicol 85:1361–1372
Smirnova L, Hogber HT, Leist M, Hartung T (2014) Developmental neurotoxicity – challenges in the 21st century and in vitro opportunities. ALTEX 31:129–156
Soto-Peña GA, Luna AL, Acosta-Saavedra L, Conde P, López-Carrillo L, Cebrián ME, Vega L (2006) Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J 20:779–781
Stølevik SB, Nygaard UC, Namork E, Haugen M, Meltzer HM, Alexander J, Granum B (2013) Prenatal exposure to polychlorinated biphenyls and dioxins from the maternal diet may be associated with immunosuppressive effects that persist into early childhood. Food Chem Toxicol 51:165–172
Tonk EC, de Groot DM, Wolterbeek AP, Penninks AH, Waalkens-Berendsen ID, Piersma AH, van Loveren H (2013) Developmental immunotoxicity of ethanol in an extended one-generation reproductive toxicity study. Arch Toxicol 87:323–335
Turner S (2012) Perinatal programming of childhood asthma: early fetal size, growth trajectory during infancy, and childhood asthma outcomes. Clin Dev Immunol 2012:962923
Vahter M (2009) Effects of arsenic on maternal and fetal health. Annu Rev Nutr 29:381–399
Weng NP, Araki Y, Subedi K (2012) The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol 12:306–315
Wilson CB, Kollmann TR (2008) Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 61:183–195
Wilson CB, Rowell E, Sekimata M (2009) Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9:91–105
Wolstenholme JT, Edwards M, Shetty SR, Gatewood JD, Taylor JA, Rissman EF, Connelly JJ (2012) Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression. Endocrinology 153:3828–3838
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
DeWitt, J.C., Keil, D.E. (2017). Current Issues in Developmental Immunotoxicity. In: Parker, G. (eds) Immunopathology in Toxicology and Drug Development. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-47377-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-47377-2_13
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-47375-8
Online ISBN: 978-3-319-47377-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)